Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 4, April 2026

    April 9, 2026

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      US Individual Life Insurance New Premium To Set New Sales Record in 2025

      March 4, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026

      Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

      April 9, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

      April 9, 2026

      Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

      April 9, 2026

      Is the Secondary Life Insurance Market in the UK Set To Re-Emerge?

      April 9, 2026

      Q&A: Brandon Marz, Co-Founder and Chief Strategy Officer, LifeRoc Capital

      March 25, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

      April 9, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

      April 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    Secondary Life Markets January 14, 2026By Greg Winterton
    Share
    Twitter LinkedIn Email

    In early December, Connecticut Superior Court Judge Daniel J. Klau granted the proposals to modify the moratorium order that was originally filed in May 2024 by Andrew Mais, Connecticut’s Insurance Commissioner at the time, in respect of the rehabilitation of PHL Variable Life Insurance Company (PHL). 

    The original order capped the payouts of maturing life insurance policies at $300,000 per individual life (regardless of the number of policies), meaning that policyowners with face value exposure greater than that amount – such as life settlement funds (which tend to buy higher face value policies) – immediately began sitting on a paper loss.  

    One significant challenge faced by policyowners was that they had to continue to pay the premiums just to keep the policies in force.  

    For the life settlement cohort, it was a case of damned if you do, damned if you don’t; the former because you’re spending money on an asset that has a ceiling of $300,000 per life insured, the latter because if you don’t keep the policy in force, you lose the whole thing.  

    But fast forward to July last year and Mais proposed modifications to the original order. 

    First, policyholders could keep the status quo. Second, they could reduce the face amount of their death benefits with correspondingly lower cost of insurance or premium payments, and third, convert their policy to a claim for a fixed amount in the rehabilitation proceedings with no ongoing cost of insurance or premium payments. 

    For Edward Stone, Partner at Edward Stone Law, these options were not as helpful as they seemed on the surface. 

    “The first choice is not a choice, and the second choice is a provision in every PHL universal life insurance policy I have reviewed – one that says you can reduce the face amount and pay less. These are not really new options. The only real new option is the adjusted surrender value – but so far, the rehabilitator has not spelled out exactly how that is going to be calculated,” he said. 

    The Connecticut Insurance Department did not return an email offering the opportunity to comment prior to publishing. 

    Still, life settlement funds with PHL policies in their portfolio will soon – if they haven’t already – receive an individualised election package asking them to make their selection. They have just 45 days from the date on the letter to do this, as Interim Insurance Commissioner and new Rehabilitator Joshua Hershman (Mais retired at the end of November) will be looking for a more accurate picture of what the actual liabilities will end up being – because he wants to liquidate PHL. 

    In a report filed on 31st December last year, Hershman concluded that a rehabilitation was not possible because “After receiving refined bids from the parties engaged in the marketing and sale process and the completion of additional due diligence by the Rehabilitator and his advisors, it has become clear that all of PHL’s blocks of business are materially impaired”. The intent to liquidate comes because Hershman “will not pursue a transaction that will deliver less value than a liquidation of the Companies”. 

    So, for the life settlement market, it’s a case of making their selections and seeing what the liquidation looks like. The report says that the Rehabilitator is in negotiations with two parties “that are willing and able to provide limited ongoing coverage or benefits above the guaranty associations’ limits, provided that they can reach agreement with the guaranty associations on also providing coverage on the portion of policies within the guaranty associations’ limits.” 

    There is little certainty here, however, and a significant haircut for policyholders holding face value beyond the $300,000 limit is on the cards. 

    While PHL’s liquidation will/would be difficult for all policyholders, not only the life settlement cohort – Stone has a client who had a $2m policy on her husband who passed away and only got the $300,000 (“she has kids in high school and hasn’t worked in 30 years – this is a concerning situation for real human beings,” he said) – the topic of carrier risk will doubtless be front and centre of investor due diligence meetings between life settlement funds and their investor clients. 

    Life settlement portfolio managers already diversify by carrier, as well as age, state, face value, sex – it’s portfolio construction 101 for the industry – but losses still hurt. 

    But if there is a silver lining to be had here, it’s that this is an isolated incident as opposed to something more fundamental.  

    “This is not a systemic issue for the life settlement market. This issue involved one life insurance company. The credit rating for life insurers in the US is generally strong, as is the regulatory environment under which they operate. It remains a benefit to the life settlement market that life insurers are the main counterparty in the space,” Troutman Pepper Locke Partner Brian Casey told this magazine last year. 

    Still, this is a saga that the life settlement market will want to end. For those owning PHL policies, however, it will be tough, and for the industry at large, it is unlikely to be quick.  

    “First of all, there needs to be a proposed liquidation plan that everyone can see. But there is the whole back and forth with the state guaranty associations and NOLHGA [the National Organization of Life & Health Insurance Guaranty Associations]. They need to figure out how much all of the folks whose claims are over the cap will get. Policyholders also need to understand that all amounts paid by State Guaranty Associations get recouped from remaining estate assets pari passu with policyholder claims, to the extent there are assets remaining after all of the under the cap claims are paid. Once the amount of under the cap claims are sorted, the Plan of Liquidation will address how and when State Guaranty Associations will contribute funds and the extent to which the over the cap claims get reduced,” said Stone.  

    “Given that PHL Variable is reporting negative surplus in excess of $2.2bn, the reductions will be very material and painful for policyholders. We are still only in the middle innings of this one – I’m not sure it gets completely resolved this year.” 

    2026 - January Life Settlements Longevity Risk Volume 2 Issue 1 – January 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026By Greg Winterton

    Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

    April 9, 2026By Greg Winterton

    Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

    April 9, 2026By Liam Bodemeaid

    Is the Secondary Life Insurance Market in the UK Set To Re-Emerge?

    April 9, 2026By Greg Winterton
    Latest Issue

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026

    Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

    April 9, 2026

    Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

    April 9, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.